Cambridge Design Partnership

Cambridge Design Partnership is an employee-owned product design and innovation consultancy with offices in Cambridge, UK and Raleigh, North Carolina. The firm specializes in bringing medical devices, drug delivery systems, and diagnostic technologies from concept to market, working with global pharmaceutical companies, medical device manufacturers, and healthcare startups.

The company's approach combines scientific rigor, design ingenuity, and engineering excellence across multi-disciplinary teams. With quality systems certified to ISO 13485:2016 and ISO 9001:2015, Cambridge Design Partnership manages the complete product development lifecycle, from initial insight and prototyping through regulatory compliance and production. Their healthcare portfolio spans diagnostics, drug delivery devices, and medical therapy equipment, with recent focus on injectable systems, respiratory devices, and surgical robotics.

Notable achievements include developing a PCR testing system during the pandemic and advancing surgical robotic technology for Titan Medical. The firm has published whitepapers on advancing injectable drug delivery systems, respiratory drug delivery, and next-generation diagnostic systems, demonstrating depth in regulated healthcare product development.

Choose Cambridge Design Partnership when developing complex medical devices or drug delivery systems that require integrated mechanical, electrical, and regulatory expertise under one roof. The firm excels in situations demanding rapid prototyping with regulatory compliance built in from the start, particularly for novel delivery mechanisms or diagnostic platforms.

Expect a structured development process with ISO-certified quality management, collaborative multi-disciplinary teams, and clear regulatory pathways. Their employee ownership model typically results in senior staff continuity throughout projects, though this may come with premium pricing reflective of their comprehensive capabilities.

Cambridge Design Partnership dedicates significant resources to healthcare innovation, with specialized practices in diagnostics, drug delivery, and medical therapy. Their ISO 13485:2016 certification specifically addresses medical device quality management requirements, while published whitepapers on injectable drug delivery and diagnostic systems demonstrate thought leadership in pharmaceutical and medical device sectors.

The firm works across the healthcare value chain, from pharmaceutical companies developing novel biologics requiring specialized delivery devices to diagnostic companies creating next-generation testing platforms. Recent projects include surgical robotics, respiratory drug delivery systems, and rapid PCR testing development, indicating breadth across medical device categories and regulatory classifications.

Ideal clients are mid-to-large pharmaceutical companies and medical device manufacturers with budgets exceeding $500K for product development initiatives. Organizations developing injectable therapies, diagnostic platforms, or complex medical devices benefit most from their regulated development expertise. Startups with substantial funding seeking a single partner to navigate from prototype to market launch also align well with their full-service model.